Highlights Rohto Pharmaceutical Co.,Ltd.

Equities

4527

JP3982400008

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-05-17 am EDT			5-day change	1st Jan Change
2,874 ^JPY	-0.55%		-8.65%	+1.09%

Apr. 04	Rohto Pharmaceutical Eyes MGO on Singapore's Eu Yan Sang International for 88 Billion Yen	MT
Apr. 04	Rohto Pharmaceutical, Mitsui & Co. to Acquire Singapore-Based Eu Yan Sang -- Update	DJ

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Rohto Pharmaceutical Eyes MGO on Singapore's Eu Yan Sang International for 88 Billion Yen	Apr. 04	MT
Rohto Pharmaceutical, Mitsui & Co. to Acquire Singapore-Based Eu Yan Sang -- Update	Apr. 04	DJ
Mitsui and Rohto to buy $594 mln Chinese medicines company Eu Yan Sang	Apr. 04	RE
Rohto Pharmaceutical, Mitsui & Co. to Acquire Singapore-Based Eu Yan Sang	Apr. 04	DJ
Rohto Pharmaceutical Co.,Ltd., Mitsui & Co., Ltd. and others agreed to acquire an 86% stake in Eu Yan Sang International Ltd from Blanca Investments Pte. Ltd., Tower Capital Asia and founding family for approximately SGD 690 million.	Apr. 03	CI
Final dividend	Mar. 27	FA
Rohto Pharmaceutical's Profit Climbs 21% in Fiscal Nine Months, Lifts Fiscal-Year Outlook	Feb. 12	MT
Japanese Shares Close Marginally Higher Monday Ahead of Biden-Xi Meeting	Nov. 13	MT
Rohto Pharmaceutical’s Attributable Profit Soars 25.8% in Fiscal H1 on Significant Profit Increases Across Categories	Nov. 12	MT
Rohto Pharmaceutical Co.,Ltd. Provides Dividend Guidance for the Full Year Ending March 31, 2024	Nov. 10	CI
Rohto Pharmaceutical Co.,Ltd. Declares Dividend for the Second Quarter of Fiscal Ending March 31, 2024, Payable on December 7, 2023	Nov. 10	CI
Rohto Pharmaceutical Co.,Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	Nov. 10	CI
Ex-dividend day for interim dividend	23-09-27	FA
Rohto Pharmaceutical Co.,Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	23-08-09	CI
Rohto Pharmaceutical Co.,Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024	23-08-09	CI
Rohto Pharmaceutical Co.,Ltd. Provides Dividend Guidance for the Second Quarter of Fiscal Year Ending March 31, 2024	23-08-09	CI
Rohto Pharmaceutical's FY23 Profit Rises Nearly 25%	23-05-23	MT
Rohto Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-11	CI
Rohto Pharmaceutical Co.,Ltd. Provides Dividend Guidance for the Second Quarter of Fiscal Year Ending March 31, 2024	23-05-11	CI
Rohto Pharmaceutical Co.,Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024	23-05-11	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Rohto Pharmaceutical Co.,Ltd.

Equities

4527

JP3982400008

Highlights

Filters